Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study.
To assess the effect of pioglitazone on renal outcome, including urinary albumin excretion and estimated glomerular filtration rate (eGFR), in diabetic patients.A prospective, randomized, open-labeled, controlled study.Taipei Veterans General Hospital.Sixty type 2 diabetic patients treated with sulf...
Main Authors: | Yu-Hsin Chen, Der-Cherng Tarng, Harn-Shen Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5094682?pdf=render |
Similar Items
-
A Histomorphological Comparative Effects of Metformin, Pioglitazone, Repaglinide and Acarbose on Polycystic Ovary in Mice
by: fariba noori, et al.
Published: (2020-04-01) -
The efficacy of pioglitazone for renal protection in diabetic kidney disease.
by: Chao-Chung Ho, et al.
Published: (2022-01-01) -
Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial.
by: Bancha Satirapoj, et al.
Published: (2018-01-01) -
A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone
by: J. A. Villarreal-Rodriguez, et al.
Published: (2020-08-01) -
Effect of Acarbose on Control of Metabolic Parameters in Patients with Diabetes Type 1
by: Amir Ziaee, et al.
Published: (2012-09-01)